Most biotech founders can name the exact moment their lab stopped feeling fast. The science is working, the pipeline has real customers waiting on it, and yet the throughput curve flattens out for reasons nobody can point to on a whiteboard. Nothing has broken. The liquid handler still runs, the plate reader still reads, and the incubator holds temperature all night. What has broken is the space between those machines, and that space is where growing research ventures quietly lose weeks.
Early on, that space gets filled by people. A scientist walks a plate from one bench to another, a technician retypes a result into a spreadsheet, and an operations lead keeps the master schedule in their head or in a shared calendar that everyone edits and nobody trusts. It works at ten runs a week. It starts to wobble at fifty, and at two hundred it becomes the single most expensive line item in the business, because the only lever left is hiring.
Workflow orchestration is the alternative, and it is less glamorous than the instruments it coordinates. It is the software layer that decides which device does what, in which order, with which sample, and it treats the lab as one system rather than a shelf of independent boxes. For a venture trying to grow testing capacity on a fixed budget, that shift in framing turns out to matter more than almost any individual piece of hardware.
The Hidden Cost of Disconnected Instruments
Lab hardware is bought one purchase order at a time, usually to solve one problem, and each vendor arrives with its own control software, its own file format, and its own idea of what a sample identifier looks like. The result is a facility full of excellent equipment that cannot talk to itself. Scientific instrumentation has always carried this integration burden, and the same tension shows up outside the life sciences whenever measurement devices multiply faster than the systems meant to coordinate them.
The cost is rarely visible in a budget line. It shows up as an instrument sitting idle for three hours because the run before it finished late and nobody was watching, as a plate reprocessed because two people booked the same window, as a result set that took a day to reconcile because the timestamps came from four clocks. NIST has been blunt about the root cause, describing the connection between laboratory hardware and the software meant to drive it as a century of design built around human operators and held together since by fragile hacks rather than robust interfaces.
Orchestration as an Operating Layer
An orchestration layer sits above the individual instruments and owns three things the humans were previously carrying: what needs to run, what is available to run it, and what happens when reality diverges from the plan. Scheduling is the visible part. A good scheduler looks at a queue of assays, a set of devices with different cycle times and constraints, and produces a plan that keeps the expensive machines busy and the cheap ones waiting, which is the opposite of what a manual calendar tends to produce.
The less visible part is recovery. Instruments fail, reagents run short, and a robot arm occasionally decides a plate is somewhere it is not. Purpose-built lab automation scheduling software can reroute the remaining work, hold the affected samples, and keep the rest of the night productive instead of surrendering the whole shift. That resilience is worth more than raw speed, because a growing venture’s real enemy is variance in delivery dates, not the theoretical maximum throughput of a single device.
Capacity Growth Without Headcount Growth
The economics here are unusually clean. R&D-performing businesses in the United States spent $722 billion on research and development in 2023, according to the National Center for Science and Engineering Statistics, and roughly 2.1 million people were employed doing that work. Labor is the dominant cost in research operations, and it is also the cost that scales linearly with volume unless something intervenes.
Orchestration intervenes at the ratio of runs to people. When the system holds the schedule, a scientist stops being a dispatcher and goes back to being a scientist. Unattended overnight and weekend operation stops requiring somebody to be physically present, which converts idle hours into capacity nobody had to pay for twice. Onboarding gets faster too, since a new hire learns one interface and a set of defined workflows rather than the accumulated folklore of six instruments.
None of that removes the need for good people. It changes what they spend their day on, and for an early commercial venture with a burn rate and a board, the difference between doubling throughput by doubling the team and doubling throughput by coordinating the equipment you already own is often the difference between the next round and the last one.
Buying Standards Rather Than Custom Glue
There is a wrong way to do this, and it is the one most ventures try first: a talented engineer writes custom scripts to stitch the instruments together. The scripts work, the engineer becomes irreplaceable, and eighteen months later a vendor firmware update takes the whole thing down on a Friday. Bespoke integration is a liability disguised as a cost saving.
The industry has been building an answer to this for years. The SiLA consortium maintains open communication and data standards for laboratory instruments precisely so that a plate reader can be interfaced with a liquid handler, or a balance connected to a LIMS, without a custom driver for every pairing. Buying into that ecosystem, and choosing an orchestration platform that speaks it, is what makes a lab expandable rather than merely automated.
The practical advice for an operations lead is to start by measuring, not buying. Track instrument utilization for two weeks, track how many hours of the working day each device is actually doing work, and track how much of a scientist’s time goes to moving things and updating records. The numbers are usually worse than anyone guessed, and they make the case internally far better than a vendor deck will.
Then scale the orchestration ahead of the hardware, not behind it. Ventures that wait until the fifth instrument arrives to think about coordination end up retrofitting a system around equipment that was never chosen with integration in mind, which is slow and expensive. Ventures that treat orchestration as infrastructure, in the same way they treat their LIMS or their quality system, buy every subsequent instrument with a clearer question in hand: how quickly does this thing plug in.
Growth in research is not really a science problem. The biology gets solved by the people you hired to solve it, and the bottleneck that stops them is almost always logistical, sitting in the gaps between machines where nobody’s job description quite reaches. Close those gaps early and the same lab, the same budget, and the same headcount will carry a venture considerably further than anyone expected.
